Welcome to our dedicated page for Henry Schein news (Ticker: HSIC), a resource for investors and traders seeking the latest updates and insights on Henry Schein stock.
Henry Schein, Inc. reports developments across its health care distribution, practice solutions, and dental technology businesses. The company serves office-based dental and medical practitioners, dental laboratories, government and institutional health care clinics, and other alternate care sites through business, clinical, technology, and supply chain solutions.
Recurring news themes include earnings releases, financial guidance, investor conference participation, board and executive governance updates, and product announcements from Henry Schein One. Recent technology coverage centers on Dentrix Ascend, a cloud-based dental platform that integrates practice management, clinical workflows, imaging, revenue cycle management, analytics, patient experience tools, and AI-enabled workflow capabilities.
Henry Schein's CEO, Stanley M. Bergman, urged the House Select Subcommittee on the Coronavirus Crisis to include primary care physicians and dentists in the national COVID-19 vaccination effort. He emphasized their importance in addressing vaccine hesitancy and their unique access across diverse communities. The letter was part of a hearing that included expert testimonies from public health leaders. Henry Schein, a Fortune 500 company, supports healthcare professionals with technology and solutions, generating $10.1 billion in sales in 2020.
Henry Schein (Nasdaq: HSIC), a leading health care solutions provider, will announce its Q1 2021 financial results on May 4, 2021, before market opening. A live webcast of the earnings conference call will be held at 10:00 a.m. Eastern Time, featuring Stanley M. Bergman and Steven Paladino. Investors can access the call via www.henryschein.com/IRwebcasts. In 2020, Henry Schein reported sales of $10.1 billion, highlighting strong growth since going public in 1995.
Henry Schein (Nasdaq: HSIC) has acquired a majority stake in Stradis Medical, enhancing its commitment to the growing ambulatory surgery market. Stradis Healthcare specializes in medical device packaging and custom procedure kits, generating approximately $39 million in sales over the past year. The deal aims to combine product offerings, improve operational efficiencies, and create new business opportunities. While the acquisition will be neutral to HSIC’s 2021 earnings per share, it is expected to be accretive thereafter. CEO Stanley Bergman highlights the strategic importance of this partnership.
Henry Schein (Nasdaq: HSIC) announced a partnership with the Black Coalition Against COVID-19 (BCAC) to support vaccine equity via the virtual town hall series, "Making It Plain." This initiative emphasizes the essential role of primary-care physicians in increasing COVID-19 vaccination accessibility, especially in minority communities. CEO Stanley M. Bergman highlighted the importance of engaging trusted healthcare providers to ensure broader vaccine distribution. The partnership aims to create additional vaccination sites across the U.S., promoting equitable access to the COVID-19 vaccine.
Henry Schein, Inc. (Nasdaq: HSIC) CEO Stanley M. Bergman supports a Congressional effort to include primary-care physicians and dentists in the national COVID-19 vaccination strategy. He highlights the importance of these trusted community figures in overcoming vaccine hesitancy, especially in underserved communities. The company commends recent amendments to the Public Readiness and Emergency Preparedness Act, expanding the pool of qualified vaccinators. With over 19,000 employees and a presence in 31 countries, Henry Schein continues to prioritize health equity while offering over 300 solutions for healthcare professionals.
The Henry Schein Cares Foundation has launched the second phase of its ‘Wearing is Caring’ campaign, aimed at improving awareness of the link between oral health and overall wellness. In partnership with The UPS Foundation, funding is directed towards the Special Olympics Healthy Athletes® programs in Louisiana, Georgia, and Mississippi, which provide crucial health screenings for athletes. The program showed significant improvements in oral health, with 67% of participants reporting no mouth pain and 25% reporting no untreated decay after care.
Henry Schein, the largest health care solutions provider for dental and medical practitioners, announced amendments to its private placement facility agreements to reinstate its share repurchase program. With $201 million authorized for future stock repurchases, this move reflects the company's ongoing commitment to increasing shareholder value. CEO Stanley M. Bergman emphasized that strong cash flow allows continued investment in strategic acquisitions and share repurchases, enhancing returns on capital.
Summary not available.
Grin has announced a partnership with Henry Schein Orthodontics to offer the Grin Remote Monitoring and Remote Consultation platforms to orthodontic practices across the U.S. This collaboration aims to streamline initial consultations, significantly reducing costs associated with patient acquisition, which can range from $900 to $1,350. The Grin Scope device, coupled with the Grin App, enables patients to self-scan their teeth, providing orthodontists with detailed videos for analysis. This innovative approach addresses the demand for convenience and safety in orthodontic care.
Henry Schein (Nasdaq: HSIC) has been recognized by Ethisphere as one of the 2021 World’s Most Ethical Companies, marking its 10th consecutive year as a honoree and the only recognition in the Healthcare Products industry. With over 19,000 Team Schein Members, the company emphasizes ethical practices as foundational to its success. Ethisphere's Ethics Index indicates honorees outperformed a comparable index by 7.1 percentage points from January 2016 to January 2021. Henry Schein operates in 31 countries, providing solutions to over 1 million customers with $10.1 billion in sales in 2020.